To the Editor: In his exploration of the health advocacy potential of modern clinicians, Gruen1 observes that the public first needs to be convinced that “the profession has its own house in order”. Unfortunately, one room in that house accommodates one of the serious health threats identified by the author: terrorism. Currently, over 95% of the world’s radiopharmaceuticals are generated from highly enriched (bomb-grade) uranium (HEU), an unnecessary nuclear weapons proliferation hazard.2 Prompt conversion of the global medical isotope supply chain to low enriched uranium (LEU, containing less than 20% uranium 235, so not viable for weapons production) is technically feasible.3 Clinicians are thus uniquely placed to advocate conversion to the use of LEU, while pressuring their imaging and isotope providers to end reliance on HEU, thereby blocking one of the most vulnerable pathways to producing a “terrorist bomb”.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Medical Association for Prevention of War (Australia), Melbourne, VIC.
- 1. Gruen RL. Evidence-based advocacy: the public roles of health care professionals [editorial]. Med J Aust 2008; 188: 684-685. <MJA full text>
- 2. Williams B, Ruff TA. Getting nuclear-bomb fuel out of radiopharmaceuticals. Lancet 2008; 371: 795-797.
- 3. Kahn LH, von Hippel F. How the radiologic and medical communities can improve nuclear security. J Am Coll Radiol 2007; 4: 248-251.
- 4. Robock A, Oman L, Stenchikov GL, et al. Climatic consequences of regional nuclear conflicts. Atmos Chem Phys 2007; 7: 2003-2012. http://www.atmos-chem-phys.org/7/2003/2007/acp-7-2003-2007.pdf (accessed Aug 2008).
- 5. Helfand I. An assessment of the extent of projected global famine resulting from limited, regional nuclear war. In: Nuclear weapons: the final pandemic. Preventing proliferation and achieving abolition. Royal Society of Medicine Conference; 2007 Oct 3-4; London, UK. http://www.ippnw.org/News/Reports/HelfandFaminePaper.pdf (accessed Jul 2008).